End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.22 HKD | 0.00% | -8.33% | -39.73% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 183.1 | 76.9 | 263.7 | 201.4 | 69.58 | 37.22 |
Enterprise Value (EV) 1 | 250.4 | 240.6 | 441.6 | 411.4 | 215.5 | 161.8 |
P/E ratio | -1.19 x | -1.81 x | -2.75 x | -1.48 x | 8.61 x | -1.15 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.29 x | 0.12 x | 0.72 x | 0.28 x | 0.08 x | 0.07 x |
EV / Revenue | 0.39 x | 0.37 x | 1.21 x | 0.57 x | 0.25 x | 0.31 x |
EV / EBITDA | -8.74 x | -16.3 x | -8.49 x | -9.71 x | 10.5 x | -25.9 x |
EV / FCF | 5.72 x | -2.97 x | 12.6 x | -14.6 x | 11.1 x | -20.3 x |
FCF Yield | 17.5% | -33.6% | 7.97% | -6.87% | 8.98% | -4.92% |
Price to Book | 1.11 x | 0.64 x | 6.96 x | -2.04 x | -0.78 x | -0.46 x |
Nbr of stocks (in thousands) | 73,237 | 73,237 | 73,237 | 73,237 | 73,237 | 101,965 |
Reference price 2 | 2.500 | 1.050 | 3.600 | 2.750 | 0.9500 | 0.3650 |
Announcement Date | 19-11-03 | 20-04-28 | 21-04-27 | 22-05-13 | 23-04-27 | 24-04-29 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 636.9 | 649.5 | 364.3 | 724.6 | 849.1 | 523.3 |
EBITDA 1 | -28.67 | -14.79 | -52.02 | -42.38 | 20.59 | -6.259 |
EBIT 1 | -38.26 | -24.82 | -63.17 | -55.06 | 14.41 | -17.71 |
Operating Margin | -6.01% | -3.82% | -17.34% | -7.6% | 1.7% | -3.38% |
Earnings before Tax (EBT) 1 | -144.4 | -33.47 | -102.1 | -129.9 | 11.77 | -23 |
Net income 1 | -153.6 | -42.42 | -95.78 | -136 | 8.079 | -28.65 |
Net margin | -24.12% | -6.53% | -26.29% | -18.77% | 0.95% | -5.48% |
EPS 2 | -2.098 | -0.5792 | -1.308 | -1.857 | 0.1103 | -0.3180 |
Free Cash Flow 1 | 43.8 | -80.92 | 35.18 | -28.25 | 19.36 | -7.97 |
FCF margin | 6.88% | -12.46% | 9.66% | -3.9% | 2.28% | -1.52% |
FCF Conversion (EBITDA) | - | - | - | - | 94.01% | - |
FCF Conversion (Net income) | - | - | - | - | 239.62% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 19-11-03 | 20-04-28 | 21-04-27 | 22-05-13 | 23-04-27 | 24-04-29 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 67.4 | 164 | 178 | 210 | 146 | 125 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -2.349 x | -11.07 x | -3.42 x | -4.955 x | 7.088 x | -19.91 x |
Free Cash Flow 1 | 43.8 | -80.9 | 35.2 | -28.3 | 19.4 | -7.97 |
ROE (net income / shareholders' equity) | -61.8% | -29.8% | -121% | 446% | -8.57% | 34.4% |
ROA (Net income/ Total Assets) | -3.74% | -2.77% | -7.31% | -6.65% | 2.02% | -2.93% |
Assets 1 | 4,105 | 1,532 | 1,310 | 2,045 | 399.7 | 977.4 |
Book Value Per Share 2 | 2.240 | 1.640 | 0.5200 | -1.350 | -1.220 | -0.7900 |
Cash Flow per Share 2 | 1.030 | 1.220 | 0.7700 | 0.9100 | 0.6800 | 1.170 |
Capex 1 | 12.8 | 15.6 | 5.77 | 9.54 | 9.81 | 13.1 |
Capex / Sales | 2.01% | 2.41% | 1.58% | 1.32% | 1.16% | 2.5% |
Announcement Date | 19-11-03 | 20-04-28 | 21-04-27 | 22-05-13 | 23-04-27 | 24-04-29 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.73% | 3.45M | |
+11.09% | 12.77B | |
+14.57% | 8.14B | |
-13.88% | 5.59B | |
+8.11% | 4.44B | |
-19.13% | 2.14B | |
-31.66% | 1.22B | |
+35.03% | 839M | |
+26.26% | 509M | |
+9.49% | 370M |
- Stock Market
- Equities
- 209 Stock
- Financials Winshine Science Company Limited